Eli Lilly and CompanyLLYNYSE
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank86
3Y CAGR+6.6%
5Y CAGR+16.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+6.6%/yr
vs +22.3%/yr prior
5Y CAGR
+16.6%/yr
Recent deceleration
Acceleration
-15.7pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 15.35 | -4.7% |
| 2024 | 16.11 | +0.6% |
| 2023 | 16.02 | +26.4% |
| 2022 | 12.68 | +29.8% |
| 2021 | 9.76 | +37.3% |
| 2020 | 7.11 | +13.9% |
| 2019 | 6.24 | +10.0% |
| 2018 | 5.67 | +18.1% |
| 2017 | 4.80 | +17.6% |
| 2016 | 4.09 | - |